Shares of an automobile industry product provider climbed on Q2 results, while a biotech jumped as its test is ready for commercialization.
Stockhouse U.S. Small and Micro-cap Stock Report for Thursday, August 7, 2008
TORONTO (SHfn) – Shares of an automobile industry product provider climbed on Q2 results, while a biotech jumped as its test is ready for commercialization.
Shares of Noble International, Ltd. (NASDAQ: NOBL, Stock Forum) climbed 69.3% to $5.40 Thursday after the Michigan-based company reported financial results for the second quarter after market close Wednesday. The provider of tailored laser-welded blanks, tubular products and roll-formed products for the automotive industry through its subsidiaries, reported diluted earnings per share of 35 cents versus 13 cents a year ago, as well as net sales of $314.9 million, up 72.4% compared with the same quarter last year. The company’s operating profit was $11.9 million compared with $6.3 million in the second quarter of 2007.
Centerline Holding Company (NYSE:CHC, Stock Forum), the parent company of alternative asset manager Centerline Capital Group announced its financial results for the second quarter Thursday. Centerline reported adjusted loss per share of 14 cents for the quarter, compared with adjusted EPS of 17 cents for the same quarter last year. Expanded direct assets under management grew to over $14.2 billion, an increase of 18.4% over the first quarter of 2008 and 36% over the second quarter of 2007, says the company, while delinquencies within the commercial mortgage-backed securities servicing portfolio stayed at all time lows. Shares of Centerline were up 25% to $2.20.
Shares of Haynes International (NASDAQ: HAYN, Stock Forum) jumped 23.3% to $53.44 after the company reported its third quarter results for fiscal 2008. The developer, manufacturer and marketer of high performance alloys, mainly for use in the aerospace, chemical processing and land-based bas turbine industries reported net revenues of $166.3 million for the quarter, up $25.3 million over the same quarter last year. The company’s net income was $17.6 million, or $1.46 per diluted share for the quarter, compared with net income of $17.7 million, or $1.49 per diluted share, for the third quarter offiscal 2007.
Texas-based Susser Holdings Corporation (NASDAQ: SUSS, Stock Forum) announced its second quarter results Thursday, reporting that total revenues increased 77.6% to a record $1.2 billion, from $692.8 million in the second quarter last year. The company’s net income was $6.7 million, or 39 cents per diluted share for the second quarter, versus net income of $6.3 million, or 37 cents per diluted share, in the same quarter last year. Susser Holdings Corporation operates 510 convenience stores in Texas, New Mexico and Oklahoma. Shares of Susser Holdings Corporation climbed 23% to $14.83.
Shares of Health Discovery Corporation (OTC:BB: HDVY, Stock Forum) were up 21.5% to 7.9 cents as the company reported that its new gene-based molecular diagnostic test for prostate cancer has successfully completed its Phase III double-blind clinical trial and is now ready for commercialization. The new prostate cancer test will be performed at Clarient's Clinical Laboratory in Aliso Viejo, California. HDC will receive 30% royalty on each test performed. Results from Phase I, Phase II and Phase III double-blinded clinical validation studies demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells as well as normal and BPH cells, says the company.
Virginia-based MCG Capital Corporation (NASDAQ: MCGC, Stock Forum) saw its shares tumble 41.7% to $2.79 Thursday after the company announced its results for the second quarter after market close Wednesday. The commercial finance company providing capital and advisory services to U.S. middle market companies reported a net loss of 96 cents per share in the second quarter, compared with net income of four cents per share in the previous quarter. This decrease primarily resulted from the recognition of $82.4 million of net unrealized losses on their investment portfolio, says the company. MCG’s revenue for the quarter was $31.1 million, a 38% decrease from the same quarter last year.
